Liver Immunity-Guided Discovery of Capsule-Permeable Protein Antigens Against Bacterial Sepsis
The capsules of invasive bacteria shield underlying antigens, limit immune clearance and hinder vaccine noncapsular antigen discovery. To address this, we developed Liver-based Vaccine Antigen Capture (L-VAC), a functional platform integrating antibody-mediated screening with in vivo visualization of hepatic bacterial clearance in mice. Applying L-VAC to Streptococcus pneumoniae identified multiple capsule-permeable proteins that induce rapid hepatic clearance of blood-borne bacteria. Immunization with these proteins, especially in a multivalent formulation, conferred broad cross-serotype protection. Spatial analyses revealed that only the proteins localized at or near the capsular surface are targetable for vaccine-induced pathogen capture in the liver sinusoids. These findings establish L-VAC as a sensitive and reliable approach for identifying protective protein antigens capable of overcoming capsule barriers, offering a promising strategy to develop broadly protective vaccines against multidrug-resistant encapsulated pathogens.
Authors
- Yanrong Wu
- Jeremy Brown (ORCID: https://orcid.org/0000-0002-5650-5361)
- HaiTeng DENG
- Qian Jin (ORCID: https://orcid.org/0009-0006-2876-0994)
- Jing-Ren Zhang
- Juanjuan Wang
- Wengweng Zeng
Institutions
- University College London (GB)
- China Agricultural University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.64898/2026.11.12.765860
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- preprint